If you're a health practitioner or health professional caring for people affected by cancer join us for this engaging event, part of the monthly Regional Cancer Partnerships Forum.
Regional experts will delve into myeloma and its diverse treatment landscape. From traditional therapies to cutting-edge innovations, learn how personalised treatment decisions are made in the absence of a one-size-fits-all solution. Discover the vital role of clinical trials in expanding treatment options and delve into the transformative potential of autologous stem cell transplantation. Don't miss this opportunity to gain a deeper understanding of myeloma treatment options.
Hear insights from the FRAIL-M trial, aimed at optimising treatment strategies for myeloma patients ineligible for transplant due to frailty. The trial also aims to improve first-line therapy for elderly multiple myeloma patients by enhancing effectiveness and reducing side effects. It seeks to determine optimal treatment doses based on patient fitness, crucial for this high-risk group. We'll explore the significance of adapting standard treatment regimens based on frailty assessment.
Treatments of myeloma have become more varied and complex over the past two decades, leading to not only newer treatments, but also patients having had multiple lines of treatments, longer survival and more complex supportive care needs. In this forum, gain an understanding on the complexities of patient care on different treatments and the supportive care needs for patients on treatment.
Prior to his appointment at University Hospital Geelong in 2002, A/Prof Campbell completed adult physician training in internal medicine at Westmead Hospital in Sydney, followed by clinical and laboratory haematology training at Royal Prince Alfred Hospital, Sydney and University College Hospital, London. In 2003, he established Victoria’s only regional autologous stem cell transplant service, in collaboration with the Royal Melbourne Hospital Bone Marrow Transplant Service. He is an active member of both the Haematology Society of Australia and New Zealand, and the Australasian Leukaemia and Lymphoma Group. His current clinical research interests include multi-centre, collaborative national and international trials in chronic lymphocytic leukaemia and multiple myeloma.
Dr Tricia Wright completed her MBBS in 2004 at the University of Melbourne, and trained at Austin Health, firstly as a medical registrar and then as a haematology laboratory and clinical registrar. She completed her training at the Royal Melbourne Hospital as a Bone Marrow Transplant registrar, and in 2013 obtained her Fellowship of the Royal College of Pathologists of Australasia.
Dr Lim is a haematologist with interest in all aspects of haematology patient care, encompassing both malignant and non-malignant haematology. She completed her clinical haematology training at the Alfred Hospital and Western Health, in addition to laboratory haematology training at Melbourne Pathology. She is passionate about providing patient-focused, holistic care for all patients with haematological disorders. Her current appointments are at Melbourne Pathology and Western Health, in addition to practicing privately as part of the Melbourne Haematology Group.
Gail’s main area of practice and interest includes the treatment of haematological malignancies, minimisation of anti-cancer therapy related adverse effects, and education on the safe use of anti-cancer therapies. She is a current committee member of the Cancer Pharmacists Group (CPG) of COSA and works with many national and international pharmacy and oncology groups.
